Work

Iptacopan monotherapy demonstrated improved clinical outcomes in a real-world cohort with paroxysmal nocturnal hemoglobinuria: Evidence from a managed access program

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-3202

Authors: Silvia Sanz, Abdulfaheem Khan, Sviatlana Rizk, Erik Houtsma, Tim Costigan, Luca Monaco

Institutions: Novartis (Spain), Novartis (India), Novartis (Switzerland), IQVIA (United States)

Language: English

Topic: Complement system in diseases

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417006019

Cites:

Cited by:

Related to: